Quality of Life in Chinese postmenopausal HR(+) early breast cancer (EBC) patients during adjuvant Aromatase Inhibitors(AIs) treatment - BC Qol NIS
Study identifier:NIS-OCN-ARI-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A prospective, multicenter, non-interventional study to evaluate Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
494
Study type
Observational
Age
50 Years - 70 Years
Date
Study Start Date: 01 Jul 2010
Primary Completion Date: 01 Oct 2013
Study Completion Date: 01 Oct 2013
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment | - |
Contacts
Investigators
Principal Investigator
Prof. Shao Zhimin
Fudan University Shanghai Cancer Center
